Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
TTS | Is the merger at a risk of falling over? | 04/02/21 | 16 | 6.3K | |||
|
|||||||
TTS | Ann: Removal from Official List | 08/07/19 | 0 | 954 | |||
|
|||||||
TTS | Ann: Confirmation of Bonds maturity and final interest payments | 05/07/19 | 0 | 865 | |||
|
|||||||
TTS | Ann: Tatts Bonds maturity and final interest payments | 05/07/19 | 0 | 528 | |||
|
|||||||
TTS | Ann: Tabcorp Chief Financial Officer Appointment | 10:33 | 0 | 512 | |||
|
|||||||
TTS | Ann: TTSHA - Suspension of Notes from Official Quotation | 25/06/19 | 0 | 546 | |||
|
|||||||
TTS | Ann: Tatts Bonds Maturity | 24/06/19 | 0 | 522 | |||
|
|||||||
TTS | Ann: Tatts Bonds Quarterly Report | 24/06/19 | 0 | 515 | |||
|
See All Discussions